Hyperoxia and Myocardial Infarction

Like post-cardiac arrest, in the immediate aftermath of a myocardial infarction, the conventional protocol has leaned towards administering oxygen with a liberality that appears to be more a matter of tradition than of empirical evidence. As anesthesia providers, our inclination to supply oxygen in such circumstances stems from a well-meaning intention to counteract the ischemic insult inflicted upon the myocardium. 

A marginal increase in arterial oxygen content, achieved by elevating the PAO2 from a normoxic level of approximately 100 mm Hg to a hyperoxic level of 600 mm Hg, augments the oxygen content by a mere 15 mL per liter of blood, or equivalently, by about 7 to 8 percent. This modest increment stands in stark contrast to the concomitant reduction in coronary blood flow, which hyperoxia precipitates by up to 29 percent. The arithmetic of this situation reveals an unfavorable trade-off: The attempt to increase oxygen supply to the myocardium via supplemental oxygen results in a net decrease in oxygen delivery due to diminished blood flow. 

The reduction in coronary blood flow engendered by hyperoxia implicates a heightened risk of exacerbating ischemic injury. In this light, the anesthesia provider should critically evaluate the physiological cost versus the benefit.

In managing patients post-MI, a more conservative approach to oxygen supplementation is warranted. This entails meticulous monitoring of arterial oxygen levels and exercising restraint in deploying supplemental oxygen, reserving it for instances of clinically evident hypoxia. Such an approach aligns with the principle of 'first, do no harm,' ensuring that our interventions adhere to the dictates of both physiological prudence and empirical evidence.